SEED Therapeutics Advances RBM39 Cancer Drug Into Phase 1
KING OF PRUSSIA, PA — SEED Therapeutics, Inc. will present early clinical and preclinical data for its experimental cancer therapy ST-01156 at the upcoming 2026 American Society of Clinical Oncology …
SEED Therapeutics Advances RBM39 Cancer Drug Into Phase 1 Read More